<DOC>
	<DOCNO>NCT02167932</DOCNO>
	<brief_summary>This study look whether participate physical activity intervention chemotherapy breast cancer prevent marker age call p16 large increase chemotherapy .</brief_summary>
	<brief_title>The Impact Physical Activity Program Biomarkers Aging During Chemotherapy Breast Cancer</brief_title>
	<detailed_description>Our research team determine p16INK4a - biomarker age -- increase dramatically chemotherapy p16 level among patient similar age lower among exercise . We hypothesize engagement physical activity chemotherapy moderate effect increase p16 level chemotherapy . To test hypothesis , propose enroll 48 patient age 21-59 Stage I-III breast cancer diagnosis start adjuvant neoadjuvant chemotherapy physical activity intervention program . Our primary objective compare change p16 baseline end chemotherapy participant study ( engaged physical activity intervention ) mean change p16 see previous study similar patient participate physical activity intervention . As secondary objective , propose evaluate ( 1 ) change treatment-related toxicity , physical function , fatigue , quality life baseline , end chemotherapy 6 month post-chemotherapy , ( 2 ) association change p16 level change measure treatment-related toxicity , physical function , fatigue , quality life , ( 3 ) association change physical activity level change measure treatment-related toxicity , physical function , fatigue , quality life .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>21 59 year age , female ( A similar trial LCCC 1226 explore physical activity woman 60 year old progress . Histologically confirm Stage I , II III breast cancer ( patient one breast cancer , recent diagnosis ) Scheduled begin appropriate adjuvant neoadjuvant chemotherapy regimen define NCCN guideline ( www.nccn.org ) . Patients receive antiHER2 therapy eligible intervention test chemotherapy portion regimen . English speaking IRB approve , sign write informed consent Approval treat physician engage moderateintensity physical activity Patientassessed ability walk engage moderate physical activity Willing able meet study requirement . One significant medical condition physician 's judgment preclude participation walk strength training intervention . Unable walk engage moderateintensity physical activity .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Walk With Ease</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Walking</keyword>
	<keyword>Younger Women</keyword>
	<keyword>Cancer</keyword>
	<keyword>p16</keyword>
	<keyword>Aging</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Biomarkers Aging</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Chemotherapy Treatment</keyword>
	<keyword>Adjuvant Chemotherapy</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
</DOC>